Skip to content
The Kids Research Institute Australia logo
Donate

Discover . Prevent . Cure .

International consensus on use of continuous glucose monitoring

This article summarizes the ATTD consensus recommendations and represents the current understanding of how CGM results can affect outcomes.

Citation:
Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, et al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017;40(12):1631-40

Keywords:
hemoglobin A1c, Article, blood glucose monitoring, cardiovascular risk, consensus development, continuous glucose monitoring, evidence based medicine, glucose blood level, glycemic control, human, hypoglycemia, insulin dependent diabetes mellitus, intermittently viewed continuous glucose monitoring, medical society, non insulin dependent diabetes mellitus, practice guideline, real time continuous glucose monitoring, risk factor ,self monitoring

Abstract:
Measurement of glycated hemoglobin (HbA1c) has been the traditional method for assessing glycemic control. However, it does not reflect intra- and interday glycemic excursions that may lead to acute events (such as hypoglycemia) or postprandial hyperglycemia, which have been linked to both microvascular and macrovascular complications. Continuous glucose monitoring (CGM), either from real-time use (rtCGM) or intermittently viewed (iCGM), addresses many of the limitations inherent in HbA1c testing and self-monitoring of blood glucose. Although both provide themeans to move beyond the HbA1c measurement as the sole marker of glycemic control, standardized metrics for analyzing CGM data are lacking. Moreover, clear criteria for matching people with diabetes to themost appropriate glucose monitoring methodologies, as well as standardized advice about howbest to use the new information they provide, have yet to be established. In February 2017, the Advanced Technologies & Treatments for Diabetes (ATTD) Congress convened an international panel of physicians, researchers, and individuals with diabetes who are expert in CGM technologies to address these issues. This article summarizes the ATTD consensus recommendations and represents the current understanding of how CGM results can affect outcomes.

hemoglobin A1c
Article
blood glucose monitoring
cardiovascular risk
consensus development
continuous glucose monitoring
evidence based medicine
glucose blood level
glycemic control
human
hypoglycemia
insulin dependent diabetes mellitus
intermittently viewed continuous glucose monitoring
medical society
non insulin dependent diabetes mellitus
practice guideline
real time continuous glucose monitoring
risk factor
self monitoring